Companies similar to AstraZeneca for Business Performance Analyst
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
![]() Maersk Business Performance Analyst Salary
3 - 12 years exp. (10 salaries) | ₹6.6 L/yr - ₹14.8 L/yr | |
![]() Huntsman International Business Performance Analyst Salary
4 - 19 years exp. (6 salaries) | ₹15 L/yr - ₹31 L/yr | |
Login to view exact salary
| ||
![]() Maersk Line Business Performance Analyst Salary
7 - 9 years exp. (4 salaries) | ₹15 L/yr - ₹18 L/yr | |
![]() IQVIA Business Performance Analyst Salary
5 - 7 years exp. (3 salaries) | ₹8.3 L/yr - ₹13.1 L/yr | |
Experience wise AstraZeneca Business Performance Analyst salaries
Last Updated: 17 Mar 2023
Experience | Avg Annual Salary |
---|---|
3 years (AmbitionBox Estimate) |
₹3.8
L/yr
- ₹10
L/yr
|
4 years (AmbitionBox Estimate) |
₹7.2
L/yr
- ₹10
L/yr
|
Login to view exact salary
| |
5 years (AmbitionBox Estimate) |
₹7.5
L/yr
- ₹9.6
L/yr
|
6 years (AmbitionBox Estimate) |
₹7
L/yr
- ₹8.9
L/yr
|
7 years (AmbitionBox Estimate) |
₹6.4
L/yr
- ₹8.2
L/yr
|
Similar Designation salaries in AstraZeneca
Top skills at AstraZeneca for Business Performance Analyst
Salary related reviews for AstraZeneca
Discover interview dos and don'ts from real experiences
Top trending discussions







AstraZeneca Business Performance Analyst Salary FAQs
- Huntsman International Business Performance Analyst Salary - ₹15.0 Lakhs to ₹31.0 Lakhs per year
- Maersk Line Business Performance Analyst Salary - ₹15.0 Lakhs to ₹18.0 Lakhs per year
- IQVIA Business Performance Analyst Salary - ₹8.3 Lakhs to ₹13.1 Lakhs per year
- Maersk Business Performance Analyst Salary - ₹6.6 Lakhs to ₹14.8 Lakhs per year
Tell us how to improve this page.
- Home >
- Salaries >
- AstraZeneca Salaries >
- AstraZeneca Business Performance Analyst Salaries
AstraZeneca Business Performance Analyst salary
in
India
ranges between ₹5.8
Lakhs to ₹10
Lakhs with an average annual salary of
₹. Salary estimates are based on
5
AstraZeneca latest salaries received from various employees of
AstraZeneca.